הימפבזי - Hympavzi
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | B02BX Other systemic hemostatics |
|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | תת-×¢××¨× - S.C |
| צ×רת ××× ×× | ת×××¡× ×××רק×, SOLUTION FOR INJECTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | HYMPAVZI is indicated for routine prophylaxis of bleeding episodes in patients 12â¯years of age and older, weighing at least 35â¯kg, with:⢠severe haemophilia A (congenital factorâ¯VIII deficiency, FVIII < 1%) without factorâ¯VIII inhibitors, or ⢠severe haemophilia B (congenital factorâ¯IX deficiency, FIX < 1%) without factorâ¯IX inhibitors. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
 ××× ×¢××× ×ר××¤× Â |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×××פ××× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | PFIZER INC., USA |
| ×©× ××¢× ×ר×ש×× | PFIZER PHARMACEUTICALS ISRAEL LTD. |
| ר×ש××× | ת×ר×× ××ש×: 3/2025. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 03/01/2026 |
השינוי האחרון נעשה בֹ־3 בינואר 2026 ב־16:57